ATCC Partners with Global Research Community to Respond to Growing Zika Crisis
Critical materials available for research and development of Zika-related diagnostics and vaccines
Manassas, VA, United StatesMarch 07, 2016
ATCC, a global leader in biological materials management and standards, is partnering with the research, academic, and public health communities to respond to the growing Zika virus crisis.
Since the widespread outbreak was announced by the Centers for Disease Control (CDC) in early 2016, ATCC has anticipated and responded to the increased demand for Zika, and is releasing additional strains to help researchers better understand the biology and progression of the virus as well as to help develop accurate diagnostics and vaccines.
“ATCC is uniquely qualified to support the Zika virus outbreak,” said Dr. Raymond Cypess, ATCC Chairman and CEO. “We’ve supported research and development for similar virus types – Dengue, Chikungunya and West Nile – and have the world’s largest and most diverse bioresource collection. Our high-quality, traceable and authenticated materials are used as reference standards for vaccines, treatments, and diagnostic tools developed to confront health threats like Zika.”
ATCC is rapidly expanding its collection of Zika virus materials to include tissue culture-adapted strains and supporting products, which can be pre-ordered now and shipped by mid-March. We are also identifying other geographically-diverse strains to add to our product portfolio.
Additional product formats, including synthetic and native nucleic acids, are planned for release in the next few months. More information about these products will be available on the ATCC Zika website shortly.
For information about culture methods, characteristics and custom services, visit the ATCC website or contact the ATCC Technical Services team at [email protected], or your local distributor.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, and people provide the scientific community with credible biological products, advanced model systems, and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a non-profit organization with headquarters in Manassas, VA, and an R&D innovation center in Gaithersburg, MD.
Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, 703-365-2700 ext. 2753